ArticleMolecules (Basel, Switzerland)2022

Determination of Osimertinib, Aumolertinib, and Furmonertinib in Human Plasma for Therapeutic Drug Monitoring by UPLC-MS/MS.

Ying Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.